PATENT CLAIM ANALYSIS

Application Number: 16061815
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "326000"]

Abstract:
Disclosed are compounds of Formula A, or a salt thereof, where Q, X, R1 and R2 are as defined herein, which compounds have properties for inhibiting Na 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain (acute, post-operative, neuropathic), or cough or itch disorders using the same.

Claim (Index 10):
A compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein, wherein Q is a moiety of the formula: wherein\n D 1  is a linear- or branched-alkyl, or a geminal-cycloalkyl moiety of up to 6 carbon atoms; and \n R 6  is optionally present as a single substituent and is linear or branched alkyl of up to 4 carbon atoms, which is optionally substituted on one or more carbon atoms thereof with \u2014CF 3 .

Metadata:
- Claim Count in Document: 27.0
- Percentile: 94.0
- Lexical Diversity: 1.41071
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15378465', '16086654', '14377478', '13808625', '10850464']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7875261403801445
- 35 USC 102 Novelty (BERT): 0.6234054492204929
- Combined Prediction Score: 0.7711140712641793
- Mean Citation Score: 415.876184
- Max Citation Score: 554.0995
- Similarity Product: 522.98776023376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test